Multimedia Release

New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA

Current sequencing methods miss gene fusions for many non-small cell lung cancer patients denying them access to targeted therapies

Peer-Reviewed Publication

Dowling & Dennis PR

ASPYRE a novel genomic assay

image: Biofidelity CMO Dr. Wendy Levin says the company has developed a novel genomic assay that can analyze DNA and RNA concurrently for NSCLC. view more 

Credit: Biofidelity

Journal

BMC Medical Genomics

DOI

10.1186/s12920-022-01363-0

Subject of Research

Not applicable

Article Title

Ultra-sensitive molecular detection of gene fusions from RNA using ASPYRE

Article Publication Date

12-Oct-2022

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.